首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptor.
【24h】

Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptor.

机译:与3D-QSAR分析串联的同源性建模:一种描述人类CB2受体激动剂结合位点的计算方法。

获取原文
获取原文并翻译 | 示例
           

摘要

CB2 receptor belongs to the large family of G-protein coupled receptors (GPCRs) controlling a wide variety of signal transduction. The recent crystallographic determination of human beta2 adrenoreceptor and its high sequence similarity with human CB2 receptor (hCB2) prompted us to compute a theoretical model of hCB2 based also on beta2 adrenoreceptor coordinates. This model has been employed to perform docking and molecular dynamic simulations on WIN-55,212-2 (CB2 agonist commonly used in binding experiments), in order to identify the putative CB2 receptor agonist binding site, followed by molecular docking studies on a series of indol-3-yl-tetramethylcyclopropyl ketone derivatives, a novel class of potent CB2 agonists. Successively, docking-based Comparative Molecular Fields Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) studies were also performed. The CoMSIA model resulted to be the more predictive, showing r(ncv)(2) = 0.96, r(cv)(2) = 0.713, SEE = 0.193, F = 125.223, and r(2)(pred) = 0.78. The obtained 3D-QSAR models allowed us to derive more complete guidelines for the design of new analogues with improved potency so as to synthesize new indoles showing high CB2 affinity.
机译:CB2受体属于控制各种信号转导的G蛋白偶联受体(GPCR)家族。人β2肾上腺素受体的最新晶体学测定及其与人CB2受体(hCB2)的高度序列相似性促使我们基于β2肾上腺素受体坐标来计算hCB2的理论模型。为了识别推定的CB2受体激动剂结合位点,已使用该模型对WIN-55,212-2(通常在结合实验中使用的CB2激动剂)进行对接和分子动力学模拟,然后对一系列吲哚进行分子对接研究-3-基-四甲基环丙基酮衍生物,一类新型的强效CB2激动剂。随后,还进行了基于对接的比较分子场分析(CoMFA)和比较分子相似性指标分析(CoMSIA)研究。 CoMSIA模型的预测性更高,显示r(ncv)(2)= 0.96,r(cv)(2)= 0.713,SEE = 0.193,F = 125.223和r(2)(pred)= 0.78。获得的3D-QSAR模型使我们能够为设计具有更高效价的新类似物而设计出更完整的指南,从而合成出具有高CB2亲和力的新吲哚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号